Skip to main content
NCBI home page
Quality in Health Care : QHC logoLink to Quality in Health Care : QHC
. 1998 Jun;7(2):109–116. doi: 10.1136/qshc.7.2.109

Effective management of stable angina

M Petticrew, M Sculpher, J Kelland, R Elliott, D Holdright, M Buxton
PMCID: PMC2483589  PMID: 10180790

Full Text

The Full Text of this article is available as a PDF (126.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman A. G., Cohen E. A., Kimball B. P., Bonan R., Ricci D. R., Webb J. G., Laramee L., Barbeau G., Traboulsi M., Corbett B. N. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993 Jul 22;329(4):228–233. doi: 10.1056/NEJM199307223290402. [DOI] [PubMed] [Google Scholar]
  2. Appelman Y. E., Piek J. J., Strikwerda S., Tijssen J. G., de Feyter P. J., David G. K., Serruys P. W., Margolis J. R., Koelemay M. J., Montauban van Swijndregt E. W. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996 Jan 13;347(8994):79–84. doi: 10.1016/s0140-6736(96)90209-3. [DOI] [PubMed] [Google Scholar]
  3. Azen S. P., Mack W. J., Cashin-Hemphill L., LaBree L., Shircore A. M., Selzer R. H., Blankenhorn D. H., Hodis H. N. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation. 1996 Jan 1;93(1):34–41. doi: 10.1161/01.cir.93.1.34. [DOI] [PubMed] [Google Scholar]
  4. Black N., Langham S., Petticrew M. Coronary revascularisation: why do rates vary geographically in the UK? J Epidemiol Community Health. 1995 Aug;49(4):408–412. doi: 10.1136/jech.49.4.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Black N., Langham S., Petticrew M. Trends in the age and sex of patients undergoing coronary revascularisation in the United Kingdom 1987-93. Br Heart J. 1994 Oct;72(4):317–320. doi: 10.1136/hrt.72.4.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boberg J., Larsen F. F., Pehrsson S. K. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group. Clin Cardiol. 1992 Aug;15(8):591–595. doi: 10.1002/clc.4960150808. [DOI] [PubMed] [Google Scholar]
  7. Cohen D. J., Breall J. A., Ho K. K., Kuntz R. E., Goldman L., Baim D. S., Weinstein M. C. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation. 1994 Apr;89(4):1859–1874. doi: 10.1161/01.cir.89.4.1859. [DOI] [PubMed] [Google Scholar]
  8. Cohen D. J., Krumholz H. M., Sukin C. A., Ho K. K., Siegrist R. B., Cleman M., Heuser R. R., Brinker J. A., Moses J. W., Savage M. P. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation. 1995 Nov 1;92(9):2480–2487. doi: 10.1161/01.cir.92.9.2480. [DOI] [PubMed] [Google Scholar]
  9. Dargie H. J., Ford I., Fox K. M. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J. 1996 Jan;17(1):104–112. doi: 10.1093/oxfordjournals.eurheartj.a014668. [DOI] [PubMed] [Google Scholar]
  10. Destors J. M., Boissel J. P., Philippon A. M., Schbath J. Controlled clinical trial of bepridil, propranolol and placebo in the treatment of exercise induced angina pectoris. B.I.S. Research Group. Fundam Clin Pharmacol. 1989;3(6):597–611. doi: 10.1111/j.1472-8206.1989.tb00462.x. [DOI] [PubMed] [Google Scholar]
  11. Dick R. J., Popma J. J., Muller D. W., Burek K. A., Topol E. J. In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol. 1991 Oct 1;68(9):879–885. doi: 10.1016/0002-9149(91)90403-8. [DOI] [PubMed] [Google Scholar]
  12. Elliott J. M., Berdan L. G., Holmes D. R., Isner J. M., King S. B., Keeler G. P., Kearney M., Califf R. M., Topol E. J. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I) Circulation. 1995 Apr 15;91(8):2158–2166. doi: 10.1161/01.cir.91.8.2158. [DOI] [PubMed] [Google Scholar]
  13. Fischman D. L., Leon M. B., Baim D. S., Schatz R. A., Savage M. P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. doi: 10.1056/NEJM199408253310802. [DOI] [PubMed] [Google Scholar]
  14. Folland E. D., Hartigan P. M., Parisi A. F. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS. J Am Coll Cardiol. 1997 Jun;29(7):1505–1511. doi: 10.1016/s0735-1097(97)00097-1. [DOI] [PubMed] [Google Scholar]
  15. Gandhi M. M., Lampe F. C., Wood D. A. Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J. 1995 Feb;73(2):193–198. doi: 10.1136/hrt.73.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gapinski J. P., VanRuiswyk J. V., Heudebert G. R., Schectman G. S. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med. 1993 Jul 12;153(13):1595–1601. [PubMed] [Google Scholar]
  17. Guermonprez J. L., Blin P., Peterlongo F. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. Eur Heart J. 1993 Jul;14 (Suppl B):30–34. doi: 10.1093/eurheartj/14.suppl_b.30. [DOI] [PubMed] [Google Scholar]
  18. Guzman L. A., Simpfendorfer C., Fix J., Franco I., Whitlow P. L. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol. 1994 Jul 1;74(1):22–25. doi: 10.1016/0002-9149(94)90485-5. [DOI] [PubMed] [Google Scholar]
  19. Hillegass W. B., Ohman E. M., Leimberger J. D., Califf R. M. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol. 1994 May 1;73(12):835–839. doi: 10.1016/0002-9149(94)90805-2. [DOI] [PubMed] [Google Scholar]
  20. Holmes D. R., Jr, Topol E. J., Califf R. M., Berdan L. G., Leya F., Berger P. B., Whitlow P. L., Safian R. D., Adelman A. G., Kellett M. A., Jr A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. Circulation. 1995 Apr 1;91(7):1966–1974. doi: 10.1161/01.cir.91.7.1966. [DOI] [PubMed] [Google Scholar]
  21. Jaglal S. B., Tu J. V., Naylor C. D. Higher in-hospital mortality in female patients following coronary artery bypass surgery: a population-based study. Provincial Adult Cardiac Care Network of Ontario. Clin Invest Med. 1995 Apr;18(2):99–107. [PubMed] [Google Scholar]
  22. Juul-Möller S., Edvardsson N., Jahnmatz B., Rosén A., Sørensen S., Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet. 1992 Dec 12;340(8833):1421–1425. doi: 10.1016/0140-6736(92)92619-q. [DOI] [PubMed] [Google Scholar]
  23. Kawanishi D. T., Reid C. L., Morrison E. C., Rahimtoola S. H. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. J Am Coll Cardiol. 1992 Feb;19(2):409–417. doi: 10.1016/0735-1097(92)90499-d. [DOI] [PubMed] [Google Scholar]
  24. Maresta A., Balducelli M., Cantini L., Casari A., Chioin R., Fabbri M., Fontanelli A., Monici Preti P. A., Repetto S., De Servi S. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation. 1994 Dec;90(6):2710–2715. doi: 10.1161/01.cir.90.6.2710. [DOI] [PubMed] [Google Scholar]
  25. Nahrendorf W., Rading A., Steinig G., van der Does R., Schlote A. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina. J Cardiovasc Pharmacol. 1992;19 (Suppl 1):S114–S116. doi: 10.1097/00005344-199219001-00022. [DOI] [PubMed] [Google Scholar]
  26. Parisi A. F., Folland E. D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992 Jan 2;326(1):10–16. doi: 10.1056/NEJM199201023260102. [DOI] [PubMed] [Google Scholar]
  27. Pocock S. J., Henderson R. A., Rickards A. F., Hampton J. R., King S. B., 3rd, Hamm C. W., Puel J., Hueb W., Goy J. J., Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995 Nov 4;346(8984):1184–1189. doi: 10.1016/s0140-6736(95)92897-9. [DOI] [PubMed] [Google Scholar]
  28. Rehnqvist N., Hjemdahl P., Billing E., Björkander I., Eriksson S. V., Forslund L., Held C., Näsman P., Wallén N. H. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) Eur Heart J. 1996 Jan;17(1):76–81. doi: 10.1093/oxfordjournals.eurheartj.a014695. [DOI] [PubMed] [Google Scholar]
  29. Reifart N., Vandormael M., Krajcar M., Göhring S., Preusler W., Schwarz F., Störger H., Hofmann M., Klöpper J., Müller S. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study. Circulation. 1997 Jul 1;96(1):91–98. doi: 10.1161/01.cir.96.1.91. [DOI] [PubMed] [Google Scholar]
  30. Rogers W. J., Coggin C. J., Gersh B. J., Fisher L. D., Myers W. O., Oberman A., Sheffield L. T. Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS) Circulation. 1990 Nov;82(5):1647–1658. doi: 10.1161/01.cir.82.5.1647. [DOI] [PubMed] [Google Scholar]
  31. Savonitto S., Ardissiono D., Egstrup K., Rasmussen K., Bae E. A., Omland T., Schjelderup-Mathiesen P. M., Marraccini P., Wahlqvist I., Merlini P. A. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1996 Feb;27(2):311–316. doi: 10.1016/0735-1097(95)00489-0. [DOI] [PubMed] [Google Scholar]
  32. Schmuziger M., Christenson J. T., Maurice J., Mosimann E., Simonet F., Velebit V. Reoperative myocardial revascularization: an analysis of 458 reoperations and 2645 single operations. Cardiovasc Surg. 1994 Oct;2(5):623–629. [PubMed] [Google Scholar]
  33. Schömig A., Neumann F. J., Kastrati A., Schühlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E. M., Richardt G., Alt E. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996 Apr 25;334(17):1084–1089. doi: 10.1056/NEJM199604253341702. [DOI] [PubMed] [Google Scholar]
  34. Sculpher M. J., Seed P., Henderson R. A., Buxton M. J., Pocock S. J., Parker J., Joy M. D., Sowton E., Hampton J. R. Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1994 Oct 1;344(8927):927–930. doi: 10.1016/s0140-6736(94)92274-8. [DOI] [PubMed] [Google Scholar]
  35. Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. doi: 10.1056/NEJM199408253310801. [DOI] [PubMed] [Google Scholar]
  36. Singh S. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152. Clin Cardiol. 1993 Jan;16(1):54–58. doi: 10.1002/clc.4960160112. [DOI] [PubMed] [Google Scholar]
  37. Sirnes P. A., Golf S., Myreng Y., Mølstad P., Emanuelsson H., Albertsson P., Brekke M., Mangschau A., Endresen K., Kjekshus J. Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol. 1996 Nov 15;28(6):1444–1451. doi: 10.1016/s0735-1097(96)00349-x. [DOI] [PubMed] [Google Scholar]
  38. Tardif J. C., Cöté G., Lespérance J., Bourassa M., Lambert J., Doucet S., Bilodeau L., Nattel S., de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med. 1997 Aug 7;337(6):365–372. doi: 10.1056/NEJM199708073370601. [DOI] [PubMed] [Google Scholar]
  39. Teirstein P. S., Massullo V., Jani S., Popma J. J., Mintz G. S., Russo R. J., Schatz R. A., Guarneri E. M., Steuterman S., Morris N. B. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997 Jun 12;336(24):1697–1703. doi: 10.1056/NEJM199706123362402. [DOI] [PubMed] [Google Scholar]
  40. Topol E. J., Ferguson J. J., Weisman H. F., Tcheng J. E., Ellis S. G., Kleiman N. S., Ivanhoe R. J., Wang A. L., Miller D. P., Anderson K. M. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA. 1997 Aug 13;278(6):479–484. doi: 10.1001/jama.278.6.479. [DOI] [PubMed] [Google Scholar]
  41. Topol E. J., Leya F., Pinkerton C. A., Whitlow P. L., Hofling B., Simonton C. A., Masden R. R., Serruys P. W., Leon M. B., Williams D. O. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med. 1993 Jul 22;329(4):221–227. doi: 10.1056/NEJM199307223290401. [DOI] [PubMed] [Google Scholar]
  42. Versaci F., Gaspardone A., Tomai F., Crea F., Chiariello L., Gioffrè P. A. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med. 1997 Mar 20;336(12):817–822. doi: 10.1056/NEJM199703203361201. [DOI] [PubMed] [Google Scholar]
  43. Vliegen H. W., van der Wall E. E., Niemeyer M. G., Holwerda N. J., Bernink P. J., de Weerd P., Bosma A. H., van der Wieken L. R., Timmermans A. J., Molhoek G. P. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1991;18 (Suppl 9):S55–S60. [PubMed] [Google Scholar]
  44. Yusuf S., Zucker D., Peduzzi P., Fisher L. D., Takaro T., Kennedy J. W., Davis K., Killip T., Passamani E., Norris R. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994 Aug 27;344(8922):563–570. doi: 10.1016/s0140-6736(94)91963-1. [DOI] [PubMed] [Google Scholar]

Articles from Quality in Health Care : QHC are provided here courtesy of BMJ Publishing Group

RESOURCES